These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15119307)

  • 1. Report from San Francisco: The 11th Conference on Retroviruses and Opportunistic Infections (CROI). The tenacity of NNRTI drug resistance.
    Persaud D; Gallant JE
    Hopkins HIV Rep; 2004 Mar; 16(2):1, 5, 15. PubMed ID: 15119307
    [No Abstract]   [Full Text] [Related]  

  • 2. Report from San Francisco: The 11th Conference on Retroviruses and Opportunistic Infections (CROI). The treatment of experienced patients and resistance mechanisms.
    Lucas GM
    Hopkins HIV Rep; 2004 Mar; 16(2):6-7, 15. PubMed ID: 15119309
    [No Abstract]   [Full Text] [Related]  

  • 3. Report from San Francisco: The 11th Conference on Retroviruses and Opportunistic Infections (CROI). Antiretroviral therapy: the naïve patient.
    Gallant JE
    Hopkins HIV Rep; 2004 Mar; 16(2):1-4. PubMed ID: 15119308
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of human immunodeficiency virus infection in pregnancy.
    Watts DH
    N Engl J Med; 2002 Jun; 346(24):1879-91. PubMed ID: 12063373
    [No Abstract]   [Full Text] [Related]  

  • 5. Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in HIV type 1 subtype C-infected infants in India.
    Kurle SN; Gangakhedkar RR; Sen S; Hayatnagarkar SS; Tripathy SP; Paranjape RS
    AIDS Res Hum Retroviruses; 2007 May; 23(5):682-5. PubMed ID: 17530993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nevirapine-induced resistance is a problem.
    S Afr Med J; 2004 May; 94(5):338. PubMed ID: 15211947
    [No Abstract]   [Full Text] [Related]  

  • 7. Selected topics from the 13th International AIDS Conference, July 9-14, 2000. Duran, South Africa.
    Stringer JS; Youle M; Sabin C; Chaisson RE; Sterling TR
    HIV Clin Trials; 2000; 1(3):100-11. PubMed ID: 11590507
    [No Abstract]   [Full Text] [Related]  

  • 8. 17th Conference on Retroviruses and Opportunistic Infections, 16-19 February, San Francisco, CA. Limits of success.
    Cohen J
    Science; 2010 Mar; 327(5970):1197. PubMed ID: 20203030
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of archived resistance after intrapartum nevirapine.
    S Afr Med J; 2004 May; 94(5):334-5. PubMed ID: 15211942
    [No Abstract]   [Full Text] [Related]  

  • 10. US Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States, February 25, 2000.
    United States Public Health Service Task Force. Perinatal HIV Guidelines Working Group
    HIV Clin Trials; 2000; 1(2):39-64. PubMed ID: 11590498
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV and pregnancy at the 12 CROI.
    Anderson JR
    Hopkins HIV Rep; 2005 Mar; 17(2):6-7, 9. PubMed ID: 16419317
    [No Abstract]   [Full Text] [Related]  

  • 12. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
    Samuel R; Paredes R; Parboosing R; Moodley P; Singh L; Naidoo A; Gordon M
    J Med Virol; 2015 Oct; 87(10):1662-7. PubMed ID: 25940687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, 8-11 February 2004: where are the breakthroughs?
    Mallon PW
    J HIV Ther; 2004 Feb; 9(1):19-22. PubMed ID: 15587480
    [No Abstract]   [Full Text] [Related]  

  • 14. Report from the 11th conference on retroviruses and opportunistic infections. Resistance.
    Feinberg J
    AIDS Clin Care; 2004 Apr; 16(4):28-9. PubMed ID: 15124583
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention. Report: HIV transmission to U.S. newborns nears extinction.
    AIDS Policy Law; 2005 Feb; 20(3):4. PubMed ID: 15744882
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiretroviral treatments to reduce mother-to-child transmission of HIV.
    Peiperl L
    HIV Clin Trials; 2001; 2(1):46-55. PubMed ID: 11590514
    [No Abstract]   [Full Text] [Related]  

  • 17. Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.
    Han J; Wang L; Jiang Y; Zhang Q; Fang L; Yao J; Wang Q
    Int J STD AIDS; 2009 Apr; 20(4):249-54. PubMed ID: 19304969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rilpivirine resistance associated mutations in HIV-1 infected pregnant women.
    Cecchini DM; Zapiola I; Rodriguez CG; Bouzas MB
    Enferm Infecc Microbiol Clin; 2015; 33(7):498-9. PubMed ID: 25639908
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of HIV drug resistance mutations in pregnant women receiving single dose Nevirapine in south India.
    Jacob MS; Durairaj A; Vijayakumari J; Srijayanth P; Sivakumar MR
    Indian J Pathol Microbiol; 2011; 54(2):359-61. PubMed ID: 21623090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unequal care sustains vertical transmission rate.
    Kasper T
    GMHC Treat Issues; 1999 Feb; 13(2):11-2. PubMed ID: 11366115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.